Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease

Physiological Genomics

Volumn 22, Issue , 2005, Pages 213-226

  Tabibiazar, Raymond ^a,d   Wagner, Roger A ^a   Ashley, Euan A ^a   King, Jennifer Y ^a   Ferrara, Rossella ^a   Spin, Joshua M ^a   Sanan, David A ^c   Narasimhan, Balasubramanian ^a   Tibshirani, Robert ^a,b   Tsao, Philip S ^a   Efron, Bradley ^a,b   Quertermous, Thomas ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Microarray; Vascular disease

Indexed keywords

ACCURACY; AGE; ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIET; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION REGULATION; GENETIC RISK; IMMUNOMODULATION; IN-STENT RESTENOSIS; LONGITUDINAL STUDY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CORONARY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED C57BL; MODELS, GENETIC; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UP-REGULATION;

EID: 25144467817     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00001.2005     Document Type: Article

References (68)

1. Archacki SR, Angheloiu G, Tian XL, Tan FL, DiPaola N, Shen GQ, Moravec C, Ellis S, Topol EJ, and Wang Q. Identification of new genes differentially expressed in coronary artery disease by expression profiling. Physiol Genomics 15: 65-74, 2003.
2. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Kittling SR, Denhardt DT, Glimcher MJ, and Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864, 2000.
3. Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S, Creminon C, Staels B, Maclouf J, and Tedgui A. Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1β. Circ Res 85: 1124-1131, 1999.
4. Biocarta BIOCARTA, http://www.biocarta.com/genes/allpathways.asp (accessed December, 2003).
5. Blake GJ and Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252: 283-294, 2002.
6. Breslow JL. Mouse models of atherosclerosis. Science 272: 685-688, 1996.
7. Burges CJC. A tutorial on support vector machines for pattern recognition. Data Mining Knowl Disc 2: 121-167, 1998.
8. Carter MG, Hamatani T, Sharov AA, Carmack CE, Qian Y, Aiba K, Ko NT, Dudekula DB, Brzoska PM, Hwang SS, and Ko MS. In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling. Genome Res 13: 1011-1021, 2003.
9. Chin KC and Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 98: 15125-15130, 2001.
10. Claeskens A, Ongenae N, Neefs JM, Cheyns P, Kaijen P, Cools M, and Kutoh E. Kevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer 82: 1123-1130, 2000.
11. Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, and Muscat GE. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem 276: 17007-17013, 2001.
12. Efron B. Large-scale simultaneous hypothesis testing: the choice of a null hypothesis. J Am Stat Assoc 99: 82-95, 2004.
13. Efron B and Tibshirani R. Empirical Bayes methods and false discovery rates for microarrays. Genet Epidemiol 23: 70-86, 2002.
14. Efron B, Tibshirani R, Storey J, and Tusher VG. Empirical Bayes analysis of a microarray experiment. J Am Stat Assoc 96: 1151-1160, 2001.
15. Faber BC, Heeneman S, Daemen MJ, and Cleutjens KB. Genes potentially involved in plaque rupture. Curr Opin Lipidol 13: 545-552, 2002.
16. Geary RL, Wong JM, Rossini A, Schwartz SM, and Adams LD. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 22: 2010-2016, 2002.
17. Gene Ontology Consortium. Gene Ontology, http://www.geneontology. org/ (accessed December, 2003).
18. Girard JP and Springer TA. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J Biol Chem 271: 4511-4517, 1996.
19. Glass CK and Witztum JL. Atherosclerosis. The road ahead. Cell 104: 503-516, 2001.
20. Glukhova MA, Kabakov AE, Frid MG, Ornatsky OI, Belkin AM, Mukhin DN, Orekhov AN, Koteliansky VE, and Smirnov VN. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 85: 9542-9546, 1988.
21. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, and Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
22. Grimsditch DC, Penfold S, Latcham J, Vidgeon-Hart M, Groot PH, and Benson GM. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile. Atherosclerosis 151: 389-397, 2000.
23. Hosokawa R, Nonaka K, Morifuji M, Shum L, and Ohishi M. TGF-β3 decreases type I collagen and scarring after labioplasty. J Dent Res 82: 558-564, 2003.
24. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, and Barnes PJ. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 99: 8921-8926, 2002.
25. Jacobsen SE, Ruscetti FW, Roberts AB, and Keller JR. TGF-β is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-β1 and TGF-β3. J Immunol 151: 4534-4544, 1993.
26. Jawien J, Nastalek P, and Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol 55: 503-517, 2004.
27. Kizu A, Shioi A, Jono S, Koyama H, Okuno Y, and Nishizawa Y. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. J Cell Biochem 93: 1011-1019, 2004.
28. Langmann T, Porsch-Ozcurumez M, Heimerl S, Probst M, Moehle C, Taher M, Borsukova H, Kielar D, Kaminski WE, Dittrich-Wengenroth E, and Schmitz G. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem 277: 14443-14450, 2002.
29. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD, and Pollack JR. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101: 811-816, 2004.
30. Li WQ, Dehnade F, and Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 166: 3491-3498, 2001.
31. Luan Y and Li H. Clustering of time-course gene expression data using a mixed-effects model with B-splines. Bioinformatics 19: 474-482, 2003.
32. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
33. McCaffrey TA, Fu C, Du B, Eksinar S, Kent KC, Bush H Jr, Kreiger K, Rosengart T, Cybulsky MI, Silverman ES, and Collins T. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 105: 653-662, 2000.
34. Mirshahi F, Vasse M, Tedgui A, Li H, Merval R, Legrand E, Vannier JP, Soria J, and Soria C. Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 13: 449-455, 2002.
35. Nakashima Y, Plump AS, Raines EW, Breslow JL, and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140, 1994.
36. Napoli C, Palinski W, Di Minno G, and D'Armiento FP. Determination of atherogenesis in apolipoprotein E-knockout mice. Nutr Metab Cardiovasc Dis 10: 209-215, 2000.
37. 40a. NCBI. National Center for Biotechnology Information Homologene, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=homologene (accessed December, 2003).
38. 40b. NHLBI. NHLBI Factbook, Fiscal Year 2003. Bethesda, MD: National Heart, Lung, and Blood Institute, 2004.
39. 40c. NHLBI. 2002 NHLBI Morbidity and Mortality Chartbook. Bethesda, MD: National Heart, Lung, and Blood Institute, 2002.
40. Nishina PM, Verstuyft J, and Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 31: 859-869, 1990.
41. Nishina PM, Wang J, Toyofuku W, Kuypers FA, Ishida BY, and Paigen B. Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids 28: 599-605, 1993.
42. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, and Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826, 2004.
43. Palmqvist P, Persson E, Conaway HH, and Lerner UH. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae. J Immunol 169: 3353-3362, 2002.
44. Park T, Yi SG, Lee S, Lee SY, Yoo DH, Ahn JI, and Lee YS. Statistical tests for identifying differentially expressed genes in time-course microarray experiments. Bioinformatics 19: 694-703, 2003.
45. Peddada SD, Lobenhofer EK, Li L, Afshari CA, Weinberg CR, and Umbach DM. Gene selection and clustering for time-course and dose-response microarray experiments using order-restricted inference. Bioinformatics 19: 834-841, 2003.
46. Rajagopal V and Rockson SG. Coronary restenosis: a review of mechanisms and management. Am J Med 115: 547-553, 2003.
47. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, and Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105: 2660-2665, 2002.
48. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, and Golub TR. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98: 15149-15154, 2001.
49. Randi AM, Biguzzi E, Falciani F, Merlini P, Blakemore S, Bramucci E, Lucreziotti S, Lennon M, Faioni EM, Ardissino D, and Mannucci PM. Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis. J Thromb Haemost 1: 829-835, 2003.
50. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, and Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463, 2003.
51. Reddick RL, Zhang SH, and Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14: 141-147, 1994.
52. Saadeddin SM, Habbab MA, and Ferns GA. Markers of inflammation and coronary artery disease. Med Sci Monit 8: RA5-RA12, 2002.
53. Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, Milano CA, Rigat F, Pittman J, Nevins JR, West M, and Goldschmidt-Clermont PJ. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 24: 1922-1927, 2004.
54. Shi W, Wang X, Tangchitpiyanond K, Wong J, Shi Y, and Lusis AJ. Atherosclerosis in C3H/HeJ mice reconstituted with apolipoprotein E-null bone marrow. Arterioscler Thromb Vasc Biol 22: 650-655, 2002.
55. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, and Nishizawa Y. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-α and oncostatin M derived from macrophages. Circ Res 91: 9-16, 2002.
56. Sobue K, Hayashi K, and Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 190: 105-118, 1999.
57. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, and Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874, 2001.
58. Stanford University Genetics Department. SOURCE. http://genome-www5. stanford.edu/cgi-bin/source/sourceSearch (accessed December, 2003).
59. Suuronen T, Huuskonen J, Pihlaja R, Kyrylenko S, and Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J Neurochem 87: 407-416, 2003.
60. Tabibiazar R, Wagner RA, Liao A, and Quertermous T. Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ Res 93: 1193-1201, 2003.
61. Tabibiazar R, Wagner RA, Spin JM, Ashley EA, Narasimhan B, Rubin EM, Efron B, Tsao PS, Tibshirani R, and Quertermous T. Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease. Arterioscler Thromb Vasc Biol 25: 302-308, 2005.
62. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, and Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525, 2001.
63. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
64. Virmani R, Kolodgie FD, Burke AP, Farb A, and Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275, 2000.
65. Wuttge DM, Sirsjo A, Eriksson P, and Stemme S. Gene expression in atherosclerotic lesion of ApoE deficient mice. Mol Med 7: 383-392, 2001.
66. Xu R and Li X. A comparison of parametric versus permutation methods with applications to general and temporal microarray gene expression data. Bioinformatics 19: 1284-1289, 2003.
67. Yeang CH, Ramaswamy S, Tamayo P, Mukherjee S, Rifkin RM, Angelo M, Reich M, Lander E, Mesirov J, and Golub T. Molecular classification of multiple tumor types. Bioinformatics 17, Suppl 1: S316-S322, 2001.
68. Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, Murr A, Klein CA, and Baeuerle PA. Transcriptome analysis reveals a role of interferon-γ in human neointima formation. Mol Cell 7: 1059-1069, 2001.